US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US20030157129A1
(en)
*
|
1995-06-23 |
2003-08-21 |
Smithkline Beecham Biologicals S.A. |
Vaccine comprising a polysaccharide antigen - carrier protein conjugate and free carrier protein
|
US7078042B2
(en)
*
|
1995-09-15 |
2006-07-18 |
Uab Research Foundation |
Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
|
PT909323E
(pt)
|
1996-01-04 |
2007-06-04 |
Novartis Vaccines & Diagnostic |
''bacterioferritina de helicobacter pilori''
|
FR2763244B1
(fr)
|
1997-05-14 |
2003-08-01 |
Pasteur Merieux Serums Vacc |
Composition vaccinale multivalente a porteur mixte
|
US20010016200A1
(en)
*
|
1998-04-23 |
2001-08-23 |
Briles David E. |
Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
|
ES2628744T3
(es)
|
1998-05-22 |
2017-08-03 |
Ottawa Hospital Research Institute |
Métodos y productos para inducir inmunidad en mucosas
|
US6797275B1
(en)
*
|
1998-12-04 |
2004-09-28 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine
|
DE60038166T2
(de)
*
|
1999-03-19 |
2009-03-12 |
Glaxosmithkline Biologicals S.A., Rixensart |
Impfstoff gegen bakterielle antigene
|
GB9925559D0
(en)
*
|
1999-10-28 |
1999-12-29 |
Smithkline Beecham Biolog |
Novel method
|
GB0108364D0
(en)
*
|
2001-04-03 |
2001-05-23 |
Glaxosmithkline Biolog Sa |
Vaccine composition
|
GB0022742D0
(en)
*
|
2000-09-15 |
2000-11-01 |
Smithkline Beecham Biolog |
Vaccine
|
EP2284181A1
(en)
|
2000-10-27 |
2011-02-16 |
Novartis Vaccines and Diagnostics S.r.l. |
Nucleic acids and proteins from streptococcus groups A and B
|
GB2370770B
(en)
*
|
2001-01-03 |
2005-06-01 |
Simon Connolly |
Uses of Streptococcus Vaccines
|
US7082569B2
(en)
|
2001-01-17 |
2006-07-25 |
Outlooksoft Corporation |
Systems and methods providing dynamic spreadsheet functionality
|
HU230490B1
(hu)
|
2001-01-23 |
2016-08-29 |
Sanofi Pasteur Inc. |
Multivalens, meningokokkusz-eredetű poliszaccharid és fehérje konjugátumát tartalmazó vakcina
|
JP5208347B2
(ja)
|
2001-02-23 |
2013-06-12 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
新規なワクチン
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
GB0109297D0
(en)
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
GB0115176D0
(en)
*
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
US8481043B2
(en)
|
2001-06-22 |
2013-07-09 |
Cpex Pharmaceuticals, Inc. |
Nasal immunization
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
GB0121591D0
(en)
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|
AR045702A1
(es)
|
2001-10-03 |
2005-11-09 |
Chiron Corp |
Composiciones de adyuvantes.
|
NZ533428A
(en)
|
2001-12-12 |
2008-03-28 |
Chiron Srl |
Immunisation against chlamydia trachomatis
|
GB0130215D0
(en)
*
|
2001-12-18 |
2002-02-06 |
Glaxosmithkline Biolog Sa |
Vaccine
|
EP1531796B1
(en)
|
2002-02-20 |
2016-09-28 |
GlaxoSmithKline Biologicals SA |
Microparticles with adsorbed polypeptide-containing molecules
|
MXPA04011249A
(es)
*
|
2002-05-14 |
2005-06-06 |
Chiron Srl |
Vacunas mucosales con adyuvante de quitosano y antigenos meningococicos.
|
EP1506007B1
(en)
*
|
2002-05-14 |
2011-06-22 |
Novartis Vaccines and Diagnostics S.r.l. |
Mucosal combination vaccines for bacterial meningitis
|
GB0302218D0
(en)
|
2003-01-30 |
2003-03-05 |
Chiron Sri |
Vaccine formulation & Mucosal delivery
|
GB0220194D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Improved vesicles
|
DE60335477D1
(de)
|
2002-10-11 |
2011-02-03 |
Novartis Vaccines & Diagnostic |
Polypeptidimpstoffe zum breiten schutz gegen hypervirulente meningokokken-linien
|
EP2314604A3
(en)
*
|
2002-10-15 |
2011-05-25 |
Intercell AG |
Nucleic acids coding for adhesion factors of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof
|
SI2395073T1
(sl)
|
2002-11-01 |
2017-12-29 |
Glaxosmithkline Biologicals S.A. |
Sušilni postopek
|
US10919956B2
(en)
|
2002-11-12 |
2021-02-16 |
The Brigham And Women's Hospital, Inc. |
Polysaccharide vaccine for staphylococcal infections
|
US20070059329A1
(en)
|
2002-11-15 |
2007-03-15 |
Nathalie Norais |
Unexpected surface proteins in meningococcus
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
JP2006512927A
(ja)
|
2002-12-11 |
2006-04-20 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
5’cpg核酸およびその使用方法
|
AU2003299994A1
(en)
|
2002-12-27 |
2004-07-29 |
Chiron Corporation |
Immunogenic compositions containing phospholpid
|
FR2850106B1
(fr)
*
|
2003-01-17 |
2005-02-25 |
Aventis Pasteur |
Conjugues obtenus par amination reductrice du polysaccharide capsulaire du pneumocoque de serotype 5
|
DK1587537T3
(da)
*
|
2003-01-30 |
2012-07-16 |
Novartis Ag |
Injicerbare vacciner mod multiple meningococ-serogrupper
|
CN1787839B
(zh)
*
|
2003-03-07 |
2011-09-28 |
惠氏控股公司 |
用于抗医院内感染的免疫的多糖-葡萄球菌表面粘附素载体蛋白缀合物
|
EP1601689B1
(en)
*
|
2003-03-13 |
2007-11-28 |
GlaxoSmithKline Biologicals S.A. |
Purification process for bacterial cytolysin
|
WO2004087153A2
(en)
|
2003-03-28 |
2004-10-14 |
Chiron Corporation |
Use of organic compounds for immunopotentiation
|
CA2528007C
(en)
|
2003-06-02 |
2012-03-27 |
Chiron Corporation |
Immunogenic compositions based on microparticles comprising adsorbed toxoid and a polysaccharide-containing antigen
|
CA2540896C
(en)
|
2003-10-02 |
2015-06-02 |
Chiron Srl |
Liquid vaccines for multiple meningococcal serogroups
|
GB0323103D0
(en)
|
2003-10-02 |
2003-11-05 |
Chiron Srl |
De-acetylated saccharides
|
GB0406013D0
(en)
|
2004-03-17 |
2004-04-21 |
Chiron Srl |
Analysis of saccharide vaccines without interference
|
GB0409745D0
(en)
|
2004-04-30 |
2004-06-09 |
Chiron Srl |
Compositions including unconjugated carrier proteins
|
DK1740217T3
(da)
|
2004-04-30 |
2011-09-26 |
Novartis Ag |
Meningokok-konjugat-vaccination
|
GB0500787D0
(en)
|
2005-01-14 |
2005-02-23 |
Chiron Srl |
Integration of meningococcal conjugate vaccination
|
US7444197B2
(en)
*
|
2004-05-06 |
2008-10-28 |
Smp Logic Systems Llc |
Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes
|
GB0410866D0
(en)
|
2004-05-14 |
2004-06-16 |
Chiron Srl |
Haemophilius influenzae
|
GB0411387D0
(en)
|
2004-05-21 |
2004-06-23 |
Chiron Srl |
Analysis of saccharide length
|
GB0413868D0
(en)
|
2004-06-21 |
2004-07-21 |
Chiron Srl |
Dimensional anlaysis of saccharide conjugates
|
CA2571710A1
(en)
|
2004-06-24 |
2006-11-02 |
Nicholas Valiante |
Small molecule immunopotentiators and assays for their detection
|
WO2006002422A2
(en)
|
2004-06-24 |
2006-01-05 |
Novartis Vaccines And Diagnostics Inc. |
Compounds for immunopotentiation
|
JP2008508320A
(ja)
|
2004-07-29 |
2008-03-21 |
カイロン コーポレイション |
Streptococcusagalactiaeのようなグラム陽性細菌に対する免疫原性組成物
|
GB0424092D0
(en)
|
2004-10-29 |
2004-12-01 |
Chiron Srl |
Immunogenic bacterial vesicles with outer membrane proteins
|
RU2432962C2
(ru)
|
2005-01-27 |
2011-11-10 |
Чилдрен'З Хоспитал Энд Рисерч Сентер Эт Окленд |
Вакцины с использованием везикул на основе gna 1870 широкого спектра действия для профилактики заболеваний, вызываемых neisseria meningitidis
|
GB0502095D0
(en)
|
2005-02-01 |
2005-03-09 |
Chiron Srl |
Conjugation of streptococcal capsular saccharides
|
NZ599345A
(en)
|
2005-02-18 |
2013-07-26 |
Novartis Vaccines & Diagnostic |
Immunogens from uropathogenic Escherichia Coli
|
WO2006089264A2
(en)
|
2005-02-18 |
2006-08-24 |
Novartis Vaccines And Diagnostics Inc. |
Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
|
GB0505518D0
(en)
|
2005-03-17 |
2005-04-27 |
Chiron Srl |
Combination vaccines with whole cell pertussis antigen
|
US7955605B2
(en)
*
|
2005-04-08 |
2011-06-07 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
US7709001B2
(en)
*
|
2005-04-08 |
2010-05-04 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
SI1868645T1
(sl)
*
|
2005-04-08 |
2012-04-30 |
Wyeth Llc |
Večvalentni pnevmokokni sestavek konjugata polisaharid-protein
|
US20070184072A1
(en)
*
|
2005-04-08 |
2007-08-09 |
Wyeth |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
WO2006113528A2
(en)
|
2005-04-18 |
2006-10-26 |
Novartis Vaccines And Diagnostics Inc. |
Expressing hepatitis b virus surface antigen for vaccine preparation
|
CA2611960C
(en)
|
2005-06-27 |
2015-05-05 |
Glaxosmithkline Biologicals S.A. |
Immunogenic compositions comprising n.meningitidis capsular saccharide conjugates
|
AU2006286228A1
(en)
|
2005-09-01 |
2007-03-08 |
Novartis Vaccines And Diagnostics Gmbh & Co Kg |
Multiple vaccination including serogroup C meningococcus
|
GB0522765D0
(en)
|
2005-11-08 |
2005-12-14 |
Chiron Srl |
Combination vaccine manufacture
|
JP5215865B2
(ja)
|
2005-11-22 |
2013-06-19 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド |
ノロウイルス抗原およびサポウイルス抗原
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
AR058592A1
(es)
*
|
2005-12-22 |
2008-02-13 |
Glaxosmithkline Biolog Sa |
Vacuna
|
KR101737464B1
(ko)
*
|
2006-01-17 |
2017-05-18 |
아르네 포르스그렌 아베 |
표면 노출된 헤모필루스 인플루엔자 단백질 (단백질 E ― pE)
|
CN101024079B
(zh)
*
|
2006-02-17 |
2012-02-01 |
福州昌晖生物工程有限公司 |
肺炎链球菌多糖-外膜蛋白结合疫苗及制备方法
|
EP1993604B1
(en)
*
|
2006-03-17 |
2015-12-02 |
The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services |
Methods for preparing complex multivalent immunogenic conjugates
|
GB0605757D0
(en)
|
2006-03-22 |
2006-05-03 |
Chiron Srl |
Separation of conjugated and unconjugated components
|
AU2007229449A1
(en)
|
2006-03-22 |
2007-10-04 |
Novartis Ag |
Regimens for immunisation with meningococcal conjugates
|
US10828361B2
(en)
|
2006-03-22 |
2020-11-10 |
Glaxosmithkline Biologicals Sa |
Regimens for immunisation with meningococcal conjugates
|
ES2536426T3
(es)
|
2006-03-23 |
2015-05-25 |
Novartis Ag |
Compuestos de imidazoquinoxalina como inmunomoduladores
|
EA015833B1
(ru)
*
|
2006-03-30 |
2011-12-30 |
Глаксосмитклайн Байолоджикалс С.А. |
Иммуногенная композиция
|
PE20080774A1
(es)
*
|
2006-03-30 |
2008-08-08 |
Glaxosmithkline Biolog Sa |
Composicion inmunogenica que comprende pnag de estafilococos conjugada con una proteina portadora y polisacarido u oligosacarido capsular de s. aureus
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
US8808707B1
(en)
|
2006-05-08 |
2014-08-19 |
Wyeth Llc |
Pneumococcal dosing regimen
|
EP2054431B1
(en)
*
|
2006-06-09 |
2011-08-31 |
Novartis AG |
Conformers of bacterial adhesins
|
GB0612854D0
(en)
|
2006-06-28 |
2006-08-09 |
Novartis Ag |
Saccharide analysis
|
AU2007285484B2
(en)
|
2006-08-16 |
2013-05-02 |
Novartis Ag |
Immunogens from uropathogenic Escherichia coli
|
DE602007007642D1
(de)
*
|
2006-10-10 |
2010-08-19 |
Wyeth Llc |
Verbesserte verfahren zur trennung von streptococcus pneumoniae-3-polysacchariden
|
GB0700136D0
(en)
|
2007-01-04 |
2007-02-14 |
Glaxosmithkline Biolog Sa |
Process for manufacturing vaccines
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
JP2010531330A
(ja)
*
|
2007-06-26 |
2010-09-24 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
肺炎連鎖球菌莢膜多糖コンジュゲートを含むワクチン
|
GB0713880D0
(en)
|
2007-07-17 |
2007-08-29 |
Novartis Ag |
Conjugate purification
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
MX2010002773A
(es)
|
2007-09-12 |
2010-03-31 |
Novartis Ag |
Antigenos mutantes de gas57 y anticuerpos de gas57.
|
JP5701058B2
(ja)
|
2007-10-19 |
2015-04-15 |
ノバルティス アーゲー |
髄膜炎菌ワクチン処方物
|
US20090124573A1
(en)
|
2007-11-09 |
2009-05-14 |
Sarkis Mazmanian |
Immunomodulating compounds and related compositions and methods
|
AU2008335457B2
(en)
|
2007-12-07 |
2015-04-16 |
Glaxosmithkline Biologicals S.A. |
Compositions for inducing immune responses
|
GB0818453D0
(en)
|
2008-10-08 |
2008-11-12 |
Novartis Ag |
Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
|
NZ586430A
(en)
|
2007-12-21 |
2012-09-28 |
Novartis Ag |
Mutant forms of streptolysin o (slo)
|
AU2009208403A1
(en)
*
|
2008-02-01 |
2009-08-06 |
Newcastle Innovation Limited |
Vaccine compositions
|
NZ587382A
(en)
|
2008-02-21 |
2012-01-12 |
Novartis Ag |
Meningococcal fhbp polypeptides
|
EP2631245A1
(en)
|
2008-03-10 |
2013-08-28 |
Children's Hospital & Research Center at Oakland |
Chimeric factor H binding proteins (fHBP) containing a heterologous B domain and methods of use
|
MX2011000823A
(es)
|
2008-07-21 |
2011-04-11 |
Brigham & Womens Hospital |
Metodos y composiciones que se relacionan con oligosacaridos sinteticos de beta-1,6 glucosamina.
|
JP5689064B2
(ja)
|
2008-10-27 |
2015-03-25 |
ノバルティス アーゲー |
精製方法
|
CA2744754A1
(en)
|
2008-12-09 |
2010-06-17 |
Pfizer Vaccines Llc |
Ige ch3 peptide vaccine
|
GB0822633D0
(en)
|
2008-12-11 |
2009-01-21 |
Novartis Ag |
Formulation
|
GB0822634D0
(en)
|
2008-12-11 |
2009-01-21 |
Novartis Ag |
Meningitis vaccines
|
AU2009329193A1
(en)
|
2008-12-17 |
2011-07-14 |
Novartis Ag |
Meningococcal vaccines including hemoglobin receptor
|
BRPI1005670A8
(pt)
|
2009-01-05 |
2017-12-26 |
Epitogenesis Inc |
composições adjuvantes e processos de uso.
|
EP2385842A1
(en)
|
2009-01-12 |
2011-11-16 |
Novartis AG |
Cna_b domain antigens in vaccines against gram positive bacteria
|
WO2010109324A1
(en)
|
2009-03-24 |
2010-09-30 |
Novartis Ag |
Combinations of meningococcal factor h binding protein and pneumococcal saccharide conjugates
|
CN102427826B
(zh)
|
2009-03-24 |
2014-11-26 |
诺华股份有限公司 |
为脑膜炎球菌因子h结合蛋白添加佐剂
|
CN109248313B
(zh)
|
2009-04-14 |
2023-01-17 |
葛兰素史密丝克莱恩生物有限公司 |
用于免疫接种以抵御金黄色葡萄球菌的组合物
|
US8668911B2
(en)
|
2009-05-14 |
2014-03-11 |
The Regents Of The University Of Michigan |
Streptococcus vaccine compositions and methods of using the same
|
PT2445522T
(pt)
|
2009-06-22 |
2017-10-04 |
Wyeth Llc |
Composições imunogénicas de antigénios de staphylococcus aureus
|
US9125951B2
(en)
|
2009-06-22 |
2015-09-08 |
Wyeth Llc |
Compositions and methods for preparing Staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
|
US8647621B2
(en)
|
2009-07-27 |
2014-02-11 |
Fina Biosolutions, Llc |
Method of producing protein-carbohydrate vaccines reduced in free carbohydrate
|
IN2012DN00446A
(no)
|
2009-07-30 |
2015-05-15 |
Pfizer Vaccines Llc |
|
NZ598458A
(en)
|
2009-08-27 |
2014-03-28 |
Novartis Ag |
Hybrid polypeptides including meningococcal fhbp sequences
|
ES2670576T3
(es)
|
2009-09-03 |
2018-05-31 |
Pfizer Vaccines Llc |
Vacuna de PCSK9
|
SG178904A1
(en)
|
2009-09-10 |
2012-04-27 |
Novartis Ag |
Combination vaccines against respiratory tract diseases
|
JP5960055B2
(ja)
|
2009-10-27 |
2016-08-02 |
ノバルティス アーゲー |
改変髄膜炎菌fHBPポリペプチド
|
MX2012004851A
(es)
|
2009-10-30 |
2012-05-22 |
Novartis Ag |
Purificacion de sacaridos capsulares de staphylococcus aureus tipo 5 y tipo 8.
|
GB0919690D0
(en)
|
2009-11-10 |
2009-12-23 |
Guy S And St Thomas S Nhs Foun |
compositions for immunising against staphylococcus aureus
|
WO2011084705A2
(en)
*
|
2009-12-17 |
2011-07-14 |
Fina Biosolutions, Llc |
Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines
|
CN102762224A
(zh)
|
2009-12-22 |
2012-10-31 |
塞尔德克斯医疗公司 |
疫苗组合物
|
GB201003333D0
(en)
|
2010-02-26 |
2010-04-14 |
Novartis Ag |
Immunogenic proteins and compositions
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
EP4036104B1
(en)
|
2010-03-30 |
2024-02-21 |
Children's Hospital & Research Center at Oakland |
Factor h binding proteins (fhbp) with altered properties and methods of use thereof
|
GB201005625D0
(en)
|
2010-04-01 |
2010-05-19 |
Novartis Ag |
Immunogenic proteins and compositions
|
EP2555753B1
(en)
|
2010-04-07 |
2018-08-01 |
California Institute of Technology |
Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
|
EP2571982A4
(en)
*
|
2010-05-20 |
2014-01-01 |
California Inst Of Techn |
ANTIGEN-SPECIFIC TREGS AND CORRESPONDING COMPOSITIONS, METHODS AND SYSTEMS
|
KR20130121699A
(ko)
|
2010-05-28 |
2013-11-06 |
테트리스 온라인, 인코포레이티드 |
상호작용 혼성 비동기 컴퓨터 게임 기반구조
|
CN102933229A
(zh)
*
|
2010-06-04 |
2013-02-13 |
惠氏有限责任公司 |
疫苗制剂
|
WO2011154863A1
(en)
|
2010-06-07 |
2011-12-15 |
Pfizer Inc. |
Her-2 peptides and vaccines
|
WO2011154878A1
(en)
|
2010-06-07 |
2011-12-15 |
Pfizer Vaccines Llc |
Ige ch3 peptide vaccine
|
AU2011268507B2
(en)
|
2010-06-25 |
2014-08-14 |
Novartis Ag |
Combinations of meningococcal factor H binding proteins
|
GB201101665D0
(en)
|
2011-01-31 |
2011-03-16 |
Novartis Ag |
Immunogenic compositions
|
CA2860331A1
(en)
|
2010-12-24 |
2012-06-28 |
Novartis Ag |
Compounds
|
US10286056B2
(en)
|
2011-01-27 |
2019-05-14 |
Glaxosmithkline Biologicals S.A. |
Adjuvant nanoemulsions with crystallisation inhibitors
|
US20140112950A1
(en)
|
2011-03-02 |
2014-04-24 |
Manmohan Singh |
Combination vaccines with lower doses of antigen and/or adjuvant
|
GB201103836D0
(en)
|
2011-03-07 |
2011-04-20 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
ES2785108T3
(es)
|
2011-03-24 |
2020-10-05 |
Glaxosmithkline Biologicals Sa |
Nanoemulsiones adyuvantes con fosfolípidos
|
EP2511295A1
(en)
|
2011-04-15 |
2012-10-17 |
Institut National De La Sante Et De La Recherche Medicale |
Compositions for preventing and/or treating an infection by an HIV-1 virus
|
US20130203980A1
(en)
|
2011-05-06 |
2013-08-08 |
Petr Gennadievich Aparin |
Exopolysaccharide of shigella sonnei bacteria, method for producing same, vaccine and pharmaceutical composition containing same
|
CN103717235A
(zh)
|
2011-06-24 |
2014-04-09 |
埃皮托吉尼西斯有限公司 |
作为抗原特异性免疫调节剂的包含选择的载体、维生素、单宁和类黄酮的组合的药物组合物
|
JP6088507B2
(ja)
|
2011-07-08 |
2017-03-01 |
ノバルティス アーゲー |
チロシンライゲーションの方法
|
GB201114923D0
(en)
|
2011-08-30 |
2011-10-12 |
Novartis Ag |
Immunogenic proteins and compositions
|
WO2013038375A2
(en)
|
2011-09-14 |
2013-03-21 |
Novartis Ag |
Methods for making saccharide-protein glycoconjugates
|
US20140235667A1
(en)
|
2011-09-22 |
2014-08-21 |
Merck Sharp & Dohme Corp. |
Imidazopyridyl compounds as aldosterone synthase inhibitors
|
AU2012335208B2
(en)
|
2011-11-07 |
2017-08-31 |
Glaxosmithkline Biologicals S.A. |
Carrier molecule comprising a spr0096 and a spr2021 antigen
|
DE102011118371B4
(de)
|
2011-11-11 |
2014-02-13 |
Novartis Ag |
Zur Impfung von Menschen geeignete Zusammensetzung, die ein Diphtherie-Toxoid umfasst, sowie Verfahren zu deren Herstellung
|
EP2592137A1
(en)
|
2011-11-11 |
2013-05-15 |
Novartis AG |
Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use
|
DE102011122891B4
(de)
|
2011-11-11 |
2014-12-24 |
Novartis Ag |
Fermentationsmedium, das frei von tierischen Bestandteilen ist, zur Herstellung von Diphtherie-Toxoiden zur Verwendung bei der Impfung von Menschen
|
GB2495341B
(en)
|
2011-11-11 |
2013-09-18 |
Novartis Ag |
Fermentation methods and their products
|
KR20140101835A
(ko)
|
2011-12-08 |
2014-08-20 |
노파르티스 아게 |
클로스트리듐 디피실레 톡신-기반 백신
|
GB201121301D0
(en)
|
2011-12-12 |
2012-01-25 |
Novartis Ag |
Method
|
AU2011384634A1
(en)
|
2011-12-29 |
2014-06-19 |
Novartis Ag |
Adjuvanted combinations of meningococcal factor H binding proteins
|
CA2865028A1
(en)
|
2012-02-24 |
2013-08-29 |
Novartis Ag |
Pilus proteins and compositions
|
US20150132339A1
(en)
|
2012-03-07 |
2015-05-14 |
Novartis Ag |
Adjuvanted formulations of streptococcus pneumoniae antigens
|
EP2822584A1
(en)
|
2012-03-08 |
2015-01-14 |
Novartis AG |
Combination vaccines with tlr4 agonists
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
US10279026B2
(en)
|
2012-04-26 |
2019-05-07 |
Glaxosmithkline Biologicals Sa |
Antigens and antigen combinations
|
EP2841096B1
(en)
|
2012-04-26 |
2020-09-30 |
GlaxoSmithKline Biologicals SA |
Antigens and antigen combinations
|
RU2609651C2
(ru)
|
2012-05-04 |
2017-02-02 |
Пфайзер Инк. |
Простатоассоциированные антигены и иммунотерапевтические схемы на основе вакцин
|
KR20150021933A
(ko)
|
2012-05-22 |
2015-03-03 |
노파르티스 아게 |
수막염구균 혈청군 x 포합체
|
KR102057217B1
(ko)
*
|
2012-06-20 |
2020-01-22 |
에스케이바이오사이언스 주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
BR112015005056A2
(pt)
|
2012-09-06 |
2017-11-21 |
Novartis Ag |
vacinas de combinação com sorogrupo b meningococcus e d/t/p
|
RU2015106745A
(ru)
|
2012-10-03 |
2016-11-27 |
Глэксосмитклайн Байолоджикалз Са |
Иммуногенные композиции
|
US20150273036A1
(en)
|
2012-10-12 |
2015-10-01 |
Glaxosmithkline Biologicals Sa |
Non-cross-linked acellular pertussis antigens for use in combination vaccines
|
US20140193451A1
(en)
*
|
2012-10-17 |
2014-07-10 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition
|
MX2015005002A
(es)
*
|
2012-10-17 |
2015-07-17 |
Glaxosmithkline Biolog Sa |
Composicion inmunogenica.
|
KR20140075201A
(ko)
*
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
KR20140075196A
(ko)
|
2012-12-11 |
2014-06-19 |
에스케이케미칼주식회사 |
다가 폐렴구균 다당류-단백질 접합체 조성물
|
TR201807340T4
(tr)
|
2013-02-01 |
2018-06-21 |
Glaxosmithkline Biologicals Sa |
Çan benzeri reseptör agonistleri içeren immünolojik kompozisyonların intradermal yoldan verilmesi.
|
JP2016521284A
(ja)
|
2013-05-10 |
2016-07-21 |
カリフォルニア インスティチュート オブ テクノロジー |
大腸ガンのプロバイオティクスによる防止および処置
|
CN112999344A
(zh)
|
2013-05-15 |
2021-06-22 |
阿尔伯达大学董事会 |
E1e2 hcv疫苗及使用方法
|
CN103386126B
(zh)
*
|
2013-06-25 |
2015-06-17 |
北京科兴生物制品有限公司 |
一种含肠道病毒抗原的多价免疫原性组合物
|
KR20180099912A
(ko)
|
2013-09-08 |
2018-09-05 |
화이자 인코포레이티드 |
나이세리아 메닌지티디스 조성물 및 그의 방법
|
WO2015095868A1
(en)
*
|
2013-12-20 |
2015-06-25 |
Wake Forest University Health Sciences |
Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines
|
CA3206112A1
(en)
|
2014-01-21 |
2015-07-30 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
AU2015208820B2
(en)
*
|
2014-01-21 |
2020-05-14 |
Pfizer Inc. |
Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
|
US11160855B2
(en)
|
2014-01-21 |
2021-11-02 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
US10279019B2
(en)
|
2014-02-11 |
2019-05-07 |
Stc.Unm |
PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the same
|
US10392424B2
(en)
|
2014-02-28 |
2019-08-27 |
Glaxosmithkline Biologicals Sa |
Modified meningococcal fHbp polypeptides
|
EP2921856B1
(en)
*
|
2014-03-18 |
2016-09-14 |
Serum Institute Of India Private Limited |
A quantitative assay for 4-pyrrolidinopyridine (4-ppy) in polysaccharide-protein conjugate vaccines
|
CN104829711B
(zh)
*
|
2014-04-08 |
2018-04-03 |
北京天成新脉生物技术有限公司 |
脑膜炎球菌荚膜多糖单克隆抗体及其应用
|
NZ766005A
(en)
|
2014-07-23 |
2024-03-22 |
Children’S Hospital & Res Center At Oakland |
Factor h binding protein variants and methods of use thereof
|
US9815886B2
(en)
|
2014-10-28 |
2017-11-14 |
Adma Biologics, Inc. |
Compositions and methods for the treatment of immunodeficiency
|
EP3034516A1
(en)
|
2014-12-19 |
2016-06-22 |
Novartis AG |
Purification of streptococcal capsular polysaccharide
|
HRP20230416T1
(hr)
|
2015-01-15 |
2023-07-07 |
Pfizer Inc. |
Imunogeni pripravci, namijenjeni upotrebi u cjepivima protiv pneumokoka
|
CN104548090B
(zh)
*
|
2015-01-27 |
2016-11-30 |
中国科学院过程工程研究所 |
一种β-葡聚糖修饰的脑膜炎多糖结合疫苗及其制备方法
|
WO2016184963A1
(en)
|
2015-05-19 |
2016-11-24 |
Innavirvax |
Treatment of hiv-infected individuals
|
US11331335B2
(en)
|
2015-06-10 |
2022-05-17 |
California Institute Of Technology |
Sepsis treatment and related compositions methods and systems
|
EP3109255A1
(en)
|
2015-06-26 |
2016-12-28 |
Institut National De La Recherche Agronomique |
Immunogenic composition
|
JP2018522885A
(ja)
|
2015-07-07 |
2018-08-16 |
アフィリス・アクチェンゲゼルシャフトAffiris Ag |
IgE介在性疾患の処置および予防のためのワクチン
|
KR102225282B1
(ko)
|
2015-07-21 |
2021-03-10 |
화이자 인코포레이티드 |
접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
|
GB201518684D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
WO2017085586A1
(en)
|
2015-11-20 |
2017-05-26 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
EA201891287A1
(ru)
|
2015-12-04 |
2018-11-30 |
Дана-Фарбер Кэнсер Инститьют, Инк. |
Вакцинация с использованием альфа 3-домена mica/b для лечения рака
|
SI3405212T1
(sl)
|
2016-01-19 |
2020-09-30 |
Pfizer Inc. |
Cepiva proti raku
|
EP3439704A1
(en)
|
2016-04-05 |
2019-02-13 |
GSK Vaccines S.r.l. |
Immunogenic compositions
|
WO2017220753A1
(en)
|
2016-06-22 |
2017-12-28 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Pneumococcal polysaccharide-protein conjugate composition
|
EP3493837B1
(en)
|
2016-08-05 |
2022-08-31 |
Sanofi Pasteur, Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
CA3031797A1
(en)
|
2016-08-05 |
2018-02-08 |
Sanofi Pasteur, Inc. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
AU2017321039B2
(en)
|
2016-09-02 |
2021-03-18 |
Glaxosmithkline Biologicals Sa |
Vaccines for Neisseria gonorrhoeae
|
WO2018065625A2
(en)
|
2016-10-07 |
2018-04-12 |
Enterome |
Immunogenic compounds for cancer therapy
|
EP3522915A2
(en)
|
2016-10-07 |
2019-08-14 |
Enterome S.A. |
Immunogenic compounds for cancer therapy
|
EP3551668A1
(en)
|
2016-12-06 |
2019-10-16 |
GlaxoSmithKline Biologicals S.A. |
Purification process for capsular polysaccharide
|
MX2019008564A
(es)
|
2017-01-20 |
2019-09-19 |
Pfizer |
Composiciones inmunogenicas para su uso en vacunas neumococicas.
|
BR112019014397A2
(pt)
|
2017-01-31 |
2020-02-11 |
Pfizer Inc. |
Composições de neisseria meningitidis e métodos das mesmas
|
US10259865B2
(en)
|
2017-03-15 |
2019-04-16 |
Adma Biologics, Inc. |
Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
|
CN110520154B
(zh)
*
|
2017-03-15 |
2023-08-04 |
株式会社Lg化学 |
多价肺炎链球菌疫苗组合物
|
WO2018178265A1
(en)
|
2017-03-31 |
2018-10-04 |
Glaxosmithkline Intellectual Property Development Limited |
Immunogenic composition, use and method of treatment
|
JP2020515587A
(ja)
|
2017-03-31 |
2020-05-28 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
免疫原性組成物、使用及び処置方法
|
US10729763B2
(en)
|
2017-06-10 |
2020-08-04 |
Inventprise, Llc |
Mixtures of polysaccharide-protein pegylated compounds
|
US10688170B2
(en)
|
2017-06-10 |
2020-06-23 |
Inventprise, Llc |
Multivalent conjugate vaccines with bivalent or multivalent conjugate polysaccharides that provide improved immunogenicity and avidity
|
CN110996994A
(zh)
|
2017-08-14 |
2020-04-10 |
葛兰素史密丝克莱恩生物有限公司 |
加强免疫应答的方法
|
BR122021023687A8
(pt)
|
2017-12-06 |
2023-02-07 |
Merck Sharp & Dohme |
Usos de composições imunogênicas multivalentes compreendendo conjugados de proteína carreadora e polissacarídeo de s. pneumoniae
|
MX2020007939A
(es)
|
2018-02-05 |
2020-09-03 |
Sanofi Pasteur Inc |
Composicion del conjugado proteina-polisacarido multivalente nuemococica.
|
EP3749357A4
(en)
|
2018-02-05 |
2022-04-20 |
Sanofi Pasteur, Inc. |
POLYVALENT PNEUMOCOCCAL POLYSACCHARIDE PROTEIN CONJUGATE COMPOSITION
|
US11633471B2
(en)
|
2018-03-06 |
2023-04-25 |
Unm Rainforest Innovations |
Compositions and methods for reducing serum triglycerides
|
SI3773689T1
(sl)
|
2018-04-11 |
2023-02-28 |
Enterome S.A. |
Antigenski peptidi za preprečevanje in zdravljenje raka
|
US20210106652A1
(en)
|
2018-04-11 |
2021-04-15 |
Enterome S.A. |
Immunogenic Compounds For Treatment Of Fibrosis, Autoimmune Diseases And Inflammation
|
AU2019256218A1
(en)
|
2018-04-18 |
2020-12-03 |
Sk Bioscience Co., Ltd. |
Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof
|
CN112673054A
(zh)
|
2018-07-19 |
2021-04-16 |
葛兰素史密丝克莱恩生物有限公司 |
用于制备干燥多糖的方法
|
JP2021533162A
(ja)
|
2018-08-07 |
2021-12-02 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
プロセス及びワクチン
|
US11260119B2
(en)
|
2018-08-24 |
2022-03-01 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
WO2020120569A2
(en)
|
2018-12-12 |
2020-06-18 |
Glaxosmithkline Biologicals Sa |
Modified carrier proteins for o-linked glycosylation
|
CA3120922A1
(en)
|
2018-12-12 |
2020-06-18 |
Pfizer Inc. |
Immunogenic multiple hetero-antigen polysaccharide-protein conjugates and uses thereof
|
US20220296695A1
(en)
|
2018-12-19 |
2022-09-22 |
Merck Sharp & Dohme Corp. |
Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
|
US20220118072A1
(en)
|
2019-02-11 |
2022-04-21 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
JP7239509B6
(ja)
|
2019-02-22 |
2023-03-28 |
ファイザー・インク |
細菌多糖類を精製するための方法
|
US20220184199A1
(en)
|
2019-04-10 |
2022-06-16 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
|
EP3956666A1
(en)
|
2019-04-18 |
2022-02-23 |
GlaxoSmithKline Biologicals S.A. |
Antigen binding proteins and assays
|
MX2021013736A
(es)
|
2019-05-10 |
2021-12-10 |
Glaxosmithkline Biologicals Sa |
Produccion de conjugados.
|
AU2020325645A1
(en)
|
2019-08-05 |
2022-02-17 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition
|
EP4009951A1
(en)
|
2019-08-05 |
2022-06-15 |
GlaxoSmithKline Biologicals S.A. |
Process for preparing a composition comprising a protein d polypeptide
|
KR20220069992A
(ko)
|
2019-09-27 |
2022-05-27 |
화이자 인코포레이티드 |
네이세리아 메닌기티디스 조성물 및 그의 방법
|
US20230105457A1
(en)
|
2019-10-16 |
2023-04-06 |
Enterome S.A. |
Immunogenic Compounds For Treatment Of Adrenal Cancer
|
EP4051696A1
(en)
|
2019-11-01 |
2022-09-07 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
LT4021487T
(lt)
|
2019-11-15 |
2024-02-12 |
Enterome S.A. |
Antigeniniai peptidai, skirti b-ląstelių piktybinių navikų prevencijai ir gydymui
|
CN114728051A
(zh)
|
2019-11-22 |
2022-07-08 |
葛兰素史克生物有限公司 |
细菌糖糖缀合物疫苗的剂量和施用
|
US20220409539A1
(en)
*
|
2019-12-30 |
2022-12-29 |
Fraunhofer Usa Inc. |
Particles for multi-dose delivery
|
IL295713A
(en)
|
2020-02-21 |
2022-10-01 |
Pfizer |
Isolation of saccharides
|
AU2021223184A1
(en)
|
2020-02-23 |
2022-08-18 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
CN111588847B
(zh)
*
|
2020-05-18 |
2023-05-26 |
广州中医药大学(广州中医药研究院) |
一种含有单磷酸化的脂质a与糖抗原的缀合物及其制备方法和应用
|
WO2021250626A2
(en)
|
2020-06-12 |
2021-12-16 |
Glaxosmithkline Biologicals Sa |
Dock tag system
|
MX2023004912A
(es)
|
2020-10-27 |
2023-05-16 |
Pfizer |
Composiciones de escherichia coli y metodos de las mismas.
|
US20240000912A1
(en)
|
2020-11-04 |
2024-01-04 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
WO2022101745A2
(en)
|
2020-11-10 |
2022-05-19 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
US20220202923A1
(en)
|
2020-12-23 |
2022-06-30 |
Pfizer Inc. |
E. coli fimh mutants and uses thereof
|
IL305313A
(en)
|
2021-02-19 |
2023-10-01 |
Sanofi Pasteur |
Recombinant meningococcal B vaccine
|
WO2022175423A1
(en)
|
2021-02-22 |
2022-08-25 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition, use and methods
|
EP4070814A1
(en)
|
2021-04-07 |
2022-10-12 |
Lama France |
Sars-cov-2 polypeptides and uses thereof
|
CA3221075A1
(en)
|
2021-05-28 |
2022-12-01 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
PE20240090A1
(es)
|
2021-05-28 |
2024-01-16 |
Pfizer |
Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados y sus usos
|
WO2023092090A1
(en)
|
2021-11-18 |
2023-05-25 |
Matrivax, Inc. |
Immunogenic fusion protein compositions and methods of use thereof
|
WO2023135515A1
(en)
|
2022-01-13 |
2023-07-20 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
KR20230116601A
(ko)
|
2022-01-28 |
2023-08-04 |
이동민 |
머신 좌표계와 영상 좌표계의 정합 방법 및 장치
|
WO2023161817A1
(en)
|
2022-02-25 |
2023-08-31 |
Pfizer Inc. |
Methods for incorporating azido groups in bacterial capsular polysaccharides
|
WO2023187127A1
(en)
|
2022-03-31 |
2023-10-05 |
Enterome S.A. |
Antigenic peptides for prevention and treatment of cancer
|
WO2023218322A1
(en)
|
2022-05-11 |
2023-11-16 |
Pfizer Inc. |
Process for producing of vaccine formulations with preservatives
|